{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:44:39Z","timestamp":1761623079308,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vacunas"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vacun.2021.12.002","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T01:46:56Z","timestamp":1643161616000},"page":"S64-S67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps?"],"prefix":"10.1016","volume":"23","author":[{"given":"Marian","family":"Simka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vacun.2021.12.002_bb0005","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vacun.2021.12.002_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients \u2014 United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vacun.2021.12.002_bb0015","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vacun.2021.12.002_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2021.05.010","article-title":"Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination","volume":"203","author":"Douxfils","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.vacun.2021.12.002_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","article-title":"Cerebral venous thrombosis after BNT162b2 mRNA SARS\u2013CoV2 vaccine","volume":"30","author":"Dias","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.vacun.2021.12.002_bb0030","article-title":"Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts","volume":"373","author":"Dryer","year":"2021","journal-title":"BMJ"},{"year":"2021","series-title":"\u201cVaccine-induced COVID-19 mimicry\u201d syndrome: splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines","author":"Kowarz","key":"10.1016\/j.vacun.2021.12.002_bb0035"},{"key":"10.1016\/j.vacun.2021.12.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102685","article-title":"Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data","volume":"122","author":"Cari","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vacun.2021.12.002_bb0045","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vacun.2021.12.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243894","article-title":"Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience","volume":"14","author":"Bano","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vacun.2021.12.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.13629","article-title":"Laboratory testing for suspected COVID-19 vaccine\u2013induced (immune) thrombotic trombocytopenia","author":"Favaloro","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.vacun.2021.12.002_bb0060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/STROKEAHA.111.635664","article-title":"Mortality of cerebral venous-sinus thrombosis in a large national sample","volume":"43","author":"Borhani Haghighi","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.vacun.2021.12.002_bb0065","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/cells9092079","article-title":"On neutrophil extracellular trap (NET) removal: what we know thus far and why so little","volume":"9","author":"Santocki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.vacun.2021.12.002_bb0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ijms22020559","article-title":"Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease","volume":"22","author":"Klopf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vacun.2021.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vacun.2021.12.002_bb0080","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e16","article-title":"Nucleocapsid and spike proteins of SARS-CoV-2 drive neutrophil extracellular trap formation","volume":"21","author":"Youn","year":"2021","journal-title":"Immune Netw"},{"key":"10.1016\/j.vacun.2021.12.002_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/vaccines9060559","article-title":"Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vacun.2021.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jth.15283","article-title":"Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vacun.2021.12.002_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1189\/jlb.3A0415-161R","article-title":"Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets","volume":"99","author":"Carestia","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vacun.2021.12.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100113","article-title":"Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patients","author":"Fisher","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vacun.2021.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(21)00762-5","article-title":"Thromboembolism and the Oxford\u2013AstraZeneca COVID-19 vaccine: side-effect or coincidence?","volume":"397","author":"\u00d8stergaard","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vacun.2021.12.002_bb0110","first-page":"1","article-title":"Chronic cerebrospinal venous insufficiency: current perspectives","volume":"2","author":"Simka","year":"2014","journal-title":"J Vasc Diagn"},{"key":"10.1016\/j.vacun.2021.12.002_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0268355521996087","article-title":"Numerical modeling of blood flow in the internal jugular vein with the use of computational fluid mechanics software","volume":"36","author":"Simka","year":"2021","journal-title":"Phlebology"},{"issue":"Suppl 1","key":"10.1016\/j.vacun.2021.12.002_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000054071","article-title":"Neutrophil activation and mediators of inflammation in chronic venous insufficiency","volume":"36","author":"Smith","year":"1999","journal-title":"J Vasc Res"},{"key":"10.1016\/j.vacun.2021.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1205e1215","DOI":"10.1016\/j.apsb.2020.04.008","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"}],"container-title":["Vacunas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1576988722000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1576988722000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:36:39Z","timestamp":1761622599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1576988722000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":25,"alternative-id":["S1576988722000036"],"URL":"https:\/\/doi.org\/10.1016\/j.vacun.2021.12.002","relation":{},"ISSN":["1576-9887"],"issn-type":[{"type":"print","value":"1576-9887"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps?","name":"articletitle","label":"Article Title"},{"value":"Vacunas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vacun.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}